References
- Vandecasteele SJ, DeVriese AS. Recent changes in vancomycin use in renal failure. Kidney Int. 2010;77:760–764.
- Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: A summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis. 2009;49:325–327.
- Kullar RK, Leonard SN, Davis SL, et al. Validation of the effectiveness of a vancomycin nomogram in achieving target trough concentrations of 15–20 mg/L suggested by the Vancomycin Consensus Guidelines. Pharmacotherapy. 2011;31:441–448.
- Yoshitsugu O, et al. Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: A cohort study. Am J Kid Dis. 2016;68:256–265.
- Crew P, Heintz SJ, Heintz BH. Vancomycin dosing and monitoring for patients with end-stage renal disease receiving intermittent hemodialysis. Am J Health Syst Pharm. 2015;72:1856–1864.
- Pai AB, Pai MP. Vancomycin dosing in high flux hemodialysis: A limited-sampling algorithm. Am J Health Syst Pharm. 2004;61:1812–1816.
- Vandecasteele SJ, De Vriese AS. Vancomycin dosing in patients on intermittent hemodialysis. Semin Dial. 2011;24:50–55.
- Ariano RE, Fine A, Sitar DS, Rexrode S, Zelenitsky SA. Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis. Am J Kidney Dis. 2005;46:681–687.
- Barth RH, DeVincenzo N. Use of vancomycin in high-flux hemodialysis: Experience with 130 courses of therapy. Kidney Int. 1996;50:929–936.
- Vandecasteele SJ, De Bacquer D, De Vriese AS. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15–20 microg/mL in persons undergoing hemodialysis. Clin Infect Dis. 2011;53:124–129.
- Touchette MA, Patel RV, Anandan JV, Dumler F, Zarowitz BJ. Vancomycin removal by high-flux polysulfone hemodialysis membranes in critically ill patients with end-stage renal disease. Am J Kidney Dis. 1995;26:469–474.
- Zelenitsky SA, Ariano RE, McCrae ML, Vercaigne LM. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis. Clin Infect Dis. 2012;55:527–533.
- Panais R, Hirsch DJ, Dipchand C, Storsley L, Finkle SN. A protocolized approach to vancomycin dosing in conventional hemodialysis. J Nephrol. 2010;23:569–574.
- Taylor ME, Allon M. Practical vancomycin dosing in hemodialysis patients in the era of emerging vancomycin resistance: A single-center experience [Letter to the editor]. Am J Kidney Dis. 2010;5:1163–1165.
- Lin SY, Shen MC, Hwang SJ, Chen TC, Chiu YW, Lu PL. Evaluation of vancomycin dosing protocols to achieve therapeutic serum concentrations in patients receiving high-flux hemodialysis [Letter to the editor]. Int J Antimicrob Agents. 2014;43:384–385.
- Reynolds DC, Waite LH, Alexander DP, DeRyke CA. Performance of a vancomycin dosage regimen developed for obese patients. Am J Health Syst Pharm. 2012;69:944–950.
- Morrill HJ, Caffrey AR, Noh E, LaPlante KL. Vancomycin dosing considerations in a real-world cohort of obese and extremely obese patients. Pharmacotherapy. 2015;35:869–875.
- Jeremiah CJ, Wills C, Bayly A, et al. Vancomycin dosing nomogram for haemodialysis patients. Nephrology. 2014;19:513–516.